Medical dictionary

Medical terminology normalized via MeSH, ICD-11, SNOMED CT.

62,341 terms indexed

• C571598(4-(3-chlorophenylamino)thieno(2,3-d)pyrimidin-6-yl)(1H-indol-2-yl)methanoneMeSH

  structure in first source

• C575425(4-(4'-chloro-2'-fluoro)phenylamino)-6,7-dimethylquinazolineMeSH
• C578489(4-(4-((R)-(tetrahydrofuran-3-yl)oxy)benzo(d)isoxazol-3-yloxymethyl)piperidin-1-ylmethyl)tetrahydropyran-4-olMeSH

  structure in first source

• C580772(4-(4-(6-amino-5-(benzo(d)oxazol-2-yl)pyridin-3-yl)-1H-pyrazol-1-yl)piperidin-1-yl)ethanoneMeSH

  a c-Met receptor tyrosine kinase inhibitor; structure in first source

• C572354(4-(4-(7-aminopyrazolo(1,5-a)pyrimidin-6-yl)phenyl)cyclohexyl)acetic acidMeSH

  structure in first source

• C577934(4-(4-(ethylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)-2-fluoro-5-methoxyphenyl)(morpholino)methanoneMeSH

  inhibits leucine-rich repeat kinase 2 (LRRK2); structure in first source

• C559837(4-(5-amino-4-carbamoylimidazol-1-yl)-2,3-dihydroxycyclopentyl) methyl phosphateMeSH

  a protein kinase C-iota inhibitor; structure in first source

• C561764(4-(dimethylamino)phenyl)(5-iodobenzofuran-2-yl)methanoneMeSH

  binds beta-amyloid plaques; structure in first source

• D008455(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium ChlorideMeSH

  A drug that selectively activates certain subclasses of muscarinic receptors and also activates postganglionic nicotinic receptors. It is commonly used experimentally to distinguish muscarinic receptor subtypes.

• C575284(4-amino-2-(thiophen-3-yl)thiazol-5-yl)(3,4,5-trimethoxyphenyl)methanoneMeSH

  has antineoplastic activity; structure in first source

• C586173(4-benzylpiperazin-1-yl)(3-methoxyquinoxalin-2-yl)methanoneMeSH
• C568958(4-chloro-2-((2-fluoro-5-(propylsulfonyl)phenyl)ethynyl)phenoxy)acetic acidMeSH

  a CRTH2 antagonist; structure in first source

• C568957(4-chloro-2-((2-methyl-5-(propylsulfonyl)phenyl)ethynyl)phenoxy)acetic acidMeSH

  a CRTH2 antagonist; structure in first source

• C584479(4-chloro-2-(piperidin-1-yl)thiazol-5-yl)(phenyl)methanoneMeSH

  structure ijn first source

• C576475(4-chlorophenyl)-(1H-imidazol-4-ylmethyl)-isopropyl-amineMeSH

  a TAAR1 partial antagonist; structure in first source

• C575841(4-chlorophenyl)-9H-indeno(2,1-d)pyrimidine-2,4-diamineMeSH

  structure in first source

• C583459(4-formyl-9-methoxy-5-methyl-naphtho(2,3-b)furan-3-yl)methyl acetateMeSH

  from Psacalium peltatum (Asteraceae); structure in first source

• C579602(4-hydroxymethyl-2,5-dioxo-imidazolidine-4-yl)-ureaMeSH

  structure in first source

• C588070(4-hydroxypyridine)(ammine)dichloroplatinum(II)MeSH

  structure in first source

• C587723(4-isopropylpiperazin-1-yl)(6-(tetrahydro-2H-pyran-4-yl)-6-azaspiro(2.5)octan-1-yl)methanoneMeSH

  a histamine-3 antagonist; structure in first source

• C588115(4-methoxybenzylthio)-6-(3-chlorobenzoyl)-5-methylpyrimidin-4(3H)-oneMeSH

  structure in first source

• C584190(4-methoxycarbonyl)cubylmethanolMeSH

  structure in first source

• C568442(4-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanoneMeSH
• C560639(4-methoxyphenyl)(3,4,5-trimethoxyphenyl)methanoneMeSH

  a tubulin inhibitor with antineoplastic activity; structure in first source

• C577701(4-methoxyphenyl)methyl isobutyrateMeSH

  structure in first source

• C587938(4-methyl-1-naphthyl)-(1-pentylindol-3-yl)methanoneMeSH

  structure in first source

• C585025(4-phenyl-2-pyrrolidon-1-yl)acetic acid phenylhydrazideMeSH
• C584221(4E,16E)-icosa-4,16-diene-1,19-diyne-3,18-diolMeSH

  antilymphangiogenic agent from a marine sponge Callyspongia sp.; structure in first source

• C578246(4H-chromeno(4,3-c)isoxazol-3-yl)methanolMeSH

  structure in first source

• C576544(4R,5S)-5-(3-hydroxy-2,6-dimethylphenyl)-4-isopropyldihydrofuran-2-oneMeSH

  isolated from Liriope muscari; strcture in first source

• C583155(4RS)-4-(1,3-1,3-benzodioxol-6-yl)-4,5-dihydropyrrolo(1,2-a)quinoxalineMeSH

  structure in first source

• C576023(4S)-4,5-dihydro-4-hydroxygeldanamycinMeSH

  geldanamycin analogs from Streptomyces hygroscopicus 17997; structure in first source

• C569271(4S)-4-(3-(18F)fluoropropyl)-L-glutamateMeSH
• C585638(4S)-4-OMe-cephalosporolide CMeSH

  from ascomycetous genus Cordyceps; structure in first source

• C583684(4S)-4-hydroxy-gweicurculactoneMeSH

  from rhizomes of Curcuma wenyujin; structure in first source

• C583809(4S)-4-isopropylcyclohex-l-enecarboxylic acid 4-O-beta-D-glucopyranosideMeSH

  from the twigs of Chamaecyparis obtusa var. breviramea f. crippsii; structure in first source

• C580733(4S,5S)-dihydroxycyclohexen-1-oneMeSH

  structure in first source

• C572475(4S,5S)-germacrone-4,5-epoxideMeSH

  from Curcuma aromatica; structure in first source

• C578398(5'-O-(bis(4-methoxyphenyl)(phenyl)methyl)-2'-deoxy-beta-D-threopentofuranosyl)hymine ethyl acetateMeSH

  structure in first source

• C587455(5,10,15,20-tetrakis(carboxy)porphyrinato)manganese(III)MeSH

  structure in first source

• C575794(5-(2-formylphenyl)-10,15,20-triphenylporphyrinato)nickel(II)MeSH

  structure in first source

• C561624(5-(3,4-dichlorophenyl)furan-2-yl)piperidine-1-ylmethanethioneMeSH

  inhibits abscisic acid signaling; structure in first source

• C561635(5-(3-(4-(2-bromo-5-fluorophenoxy)piperidin-1-yl)isoxazol-5-yl)-2H-tetrazol-2-yl)acetic acidMeSH

  structure in first source

• C559897(5-(4-amino-6-bromo-5-carbamoyl-1H-pyrrolo(2,3-d)pyrimidin-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl isobutyrateMeSH

  ibutocydine is the (2S,3S,4S,5S)-isomer; prodrug of BMK-Y101; antineoplastic agent that inhibits both Cdk7 and Cdk9; structure in first source

• C569010(5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl)(piperidin-1-yl)methanoneMeSH

  structure in first source

• C574632(5-(methoxymethyl)-7-(1-methyl-1H-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo(1,5-a)pyrimidin-6-yl)(2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanoneMeSH

  an I(Kur) inhibitor; structure in first source

• C586469(5-(p-fluorophenyl)-2-ureido)thiophene-3-carboxamideMeSH
• C569481(5-amino-3-methyl-6-methoxybenzo(b)furan-2-yl)(3,4,5-trimethoxyphenyl) methanoneMeSH

  activates caspases 3, 8, and 9; a tubulin inhibitor and antineoplastic agent; structure in first source

• C585470(5-chloro-1H-indol-2-yl)(1-(chloromethyl)-1,2-dihydropyrrolo(3,2-e)indol-3(6H)-yl)methanoneMeSH

  rendered into a cytotoxic compounds by CYP2W1; structure in first source

• C574903(5-dansyloxy-3-hydroxynaphthalen-2-yl)methylMeSH

  structure in first source